The proliferation (Figure 3E) and apoptosis assay (Figure 3F–3H) demonstrated that inhibition of PKA was able to abrogate the tumor-killing effects of Roflumilast via down-regulating the expression of FtMt in OVCAR3 and SKOV3 cells. This evidence concerns the gene FTMT and neoplasm.